Chronic myelomonocytic leukemia (CMML) has been a challenging disease to tackle, historically treated with therapies meant for other conditions. But there’s a new wave of hope!

Join us as Dr. Eric Padron of Moffitt Cancer Center and Dr. Lee Greenberger of The Leukemia & Lymphoma Society unveil the groundbreaking new CMML Initiative, fueled by recent funding aimed at revolutionizing treatment. Discover how this initiative is paving the way for individualized therapies that promise to enhance the quality of life for CMML patients and bring us closer to a cure.

Mentioned on this episode: 

• 
  
• Chronic myelomonocytic leukemia
  
  
• CMML classification system
  
  
• National Institutes of Health (NIH)
  
  
• National Cancer Institute (NCI)
  
  
• CMML Special Initiative
  
  
• Stem cell transplantation
  
  
• Graft-vs-host disease
  
  
• Clinical Trial Support Center
  
  
• Mike & Sofia Segal Foundation
  
  
• Treating Rare Disease with Compassion: Chronic Myelomonocytic Leukemia (CMML) podcast episode
  

Additional LLS Support Resources: 

• 
  
• Information Specialists 
  
  
• Free Nutrition Consultations
  
  
• Financial support
  
  
• Free telephone/web patient programs 
  
  
• Free booklets 
  
  
• Young Adult Resources
  
  
• Online chats 
  
  
• LLS Community 
  
  
• Support groups 
  
  
• Caregiver support 
  
  
• Caregiver Workbook
  
  
• Advocacy and Public Policy
  
  
• Survivorship Workbook
  
  
• Treating Rare Disease with Compassion: Chronic Myelomonocytic Leukemia (CMML) podcast episode
  

Support for this episode is provided by Taiho Oncology, Inc.

The post Advancing the Science: Chronic Myelomonocytic Leukemia (CMML) first appeared on The Bloodline with LLS.